SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Anderson Peter) "

Sökning: WFRF:(Anderson Peter)

  • Resultat 341-350 av 371
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
341.
  • Traylor, Matthew, et al. (författare)
  • Genetic basis of lacunar stroke : a pooled analysis of individual patient data and genome-wide association studies
  • 2021
  • Ingår i: The Lancet Neurology. - 1474-4422. ; 20:5, s. 351-361
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: The genetic basis of lacunar stroke is poorly understood, with a single locus on 16q24 identified to date. We sought to identify novel associations and provide mechanistic insights into the disease. Methods: We did a pooled analysis of data from newly recruited patients with an MRI-confirmed diagnosis of lacunar stroke and existing genome-wide association studies (GWAS). Patients were recruited from hospitals in the UK as part of the UK DNA Lacunar Stroke studies 1 and 2 and from collaborators within the International Stroke Genetics Consortium. Cases and controls were stratified by ancestry and two meta-analyses were done: a European ancestry analysis, and a transethnic analysis that included all ancestry groups. We also did a multi-trait analysis of GWAS, in a joint analysis with a study of cerebral white matter hyperintensities (an aetiologically related radiological trait), to find additional genetic associations. We did a transcriptome-wide association study (TWAS) to detect genes for which expression is associated with lacunar stroke; identified significantly enriched pathways using multi-marker analysis of genomic annotation; and evaluated cardiovascular risk factors causally associated with the disease using mendelian randomisation. Findings: Our meta-analysis comprised studies from Europe, the USA, and Australia, including 7338 cases and 254 798 controls, of which 2987 cases (matched with 29 540 controls) were confirmed using MRI. Five loci (ICA1L-WDR12-CARF-NBEAL1, ULK4, SPI1-SLC39A13-PSMC3-RAPSN, ZCCHC14, ZBTB14-EPB41L3) were found to be associated with lacunar stroke in the European or transethnic meta-analyses. A further seven loci (SLC25A44-PMF1-BGLAP, LOX-ZNF474-LOC100505841, FOXF2-FOXQ1, VTA1-GPR126, SH3PXD2A, HTRA1-ARMS2, COL4A2) were found to be associated in the multi-trait analysis with cerebral white matter hyperintensities (n=42 310). Two of the identified loci contain genes (COL4A2 and HTRA1) that are involved in monogenic lacunar stroke. The TWAS identified associations between the expression of six genes (SCL25A44, ULK4, CARF, FAM117B, ICA1L, NBEAL1) and lacunar stroke. Pathway analyses implicated disruption of the extracellular matrix, phosphatidylinositol 5 phosphate binding, and roundabout binding (false discovery rate <0·05). Mendelian randomisation analyses identified positive associations of elevated blood pressure, history of smoking, and type 2 diabetes with lacunar stroke. Interpretation: Lacunar stroke has a substantial heritable component, with 12 loci now identified that could represent future treatment targets. These loci provide insights into lacunar stroke pathogenesis, highlighting disruption of the vascular extracellular matrix (COL4A2, LOX, SH3PXD2A, GPR126, HTRA1), pericyte differentiation (FOXF2, GPR126), TGF-β signalling (HTRA1), and myelination (ULK4, GPR126) in disease risk. Funding: British Heart Foundation.
  •  
342.
  • Traylor, Matthew, et al. (författare)
  • Genetic Variation at 16q24.2 is associated with small vessel stroke.
  • 2017
  • Ingår i: Annals of neurology. - : Wiley. - 1531-8249 .- 0364-5134. ; 81:3, s. 383-394
  • Tidskriftsartikel (refereegranskat)abstract
    • Genome-wide association studies (GWAS) have been successful at identifying associations with stroke and stroke subtypes, but have not yet identified any associations solely with small vessel stroke (SVS). SVS comprises a quarter of all ischaemic stroke and is a major manifestation of cerebral small vessel disease, the primary cause of vascular cognitive impairment. Studies across neurological traits have shown younger onset cases have an increased genetic burden. We leveraged this increased genetic burden by performing an age-at-onset informed GWAS meta-analysis, including a large younger onset SVS population, to identify novel associations with stroke.We used a three-stage age-at-onset informed GWAS to identify novel genetic variants associated with stroke. On identifying a novel locus associated with SVS, we assessed its influence on other small vessel disease phenotypes, as well as on mRNA expression of nearby genes, and on DNA methylation of nearby CpG sites in whole blood and in the fetal brain.We identified an association with SVS in 4,203 cases and 50,728 controls on chromosome 16q24.2 (OR(95% CI)=1.16(1.10-1.22); p=3.2x10(-9) ). The lead SNP (rs12445022) was also associated with cerebral white matter hyperintensities (OR(95% CI)=1.10(1.05-1.16); p=5.3x10(-5) ; N=3,670), but not intracerebral haemorrhage (OR(95% CI)=0.97(0.84-1.12); p=0.71; 1,545 cases, 1,481 controls). rs12445022 is associated with mRNA expression of ZCCHC14 in arterial tissues (p=9.4x10(-7) ), and DNA methylation at probe cg16596957 in whole blood (p=5.3x10(-6) ).16q24.2 is associated with SVS. Associations of the locus with expression of ZCCHC14 and DNA methylation suggest the locus acts through changes to regulatory elements. This article is protected by copyright. All rights reserved.
  •  
343.
  • Tyrrell, Chris J., et al. (författare)
  • Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration
  • 2006
  • Ingår i: BJU International. - 1464-4096. ; 98:3, s. 563-572
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE To evaluate the pharmacokinetics, tolerability and effect on endocrinology of bicalutamide given as once-daily monotherapy at doses of > 150 mg to patients with locally advanced (MO) or metastatic (M1) prostate cancer, with efficacy as a secondary endpoint. PATIENTS AND METHODS Patients were initially enrolled to receive bicalutamide 300 mg in a non-randomized phase, after which further patients were randomized to higher bicalutamide doses (in 150 mg increments) or castration. Overall, 248 patients received bicalutamide at 300 mg (21), 450 mg (95) or 600 mg (42), or castration (90). RESULTS Systemic exposure to bicalutamide stabilised at a dose of approximate to 300 mg, as determined by pharmacokinetic analysis. The tolerability of high doses of bicalutamide was similar to that of the 150 mg dose, with no increase in the incidence of adverse events. Patients receiving bicalutamide had early increases in the mean levels of oestradiol, testosterone and luteinizing hormone, which were maintained throughout the study. Levels of these hormones rapidly decreased in the castration group and remained low. From baseline (first day of treatment) to 12 weeks there was an equivalent reduction in prostate-specific antigen (PSA) levels across all four groups. At a median follow-up of 5 years, there was no significant survival difference between patients who received bicalutamide and those who received castration, either in M0 or M1 disease. CONCLUSION The low median PSA level (180 ng/mL) of patients with M1 disease might account for the lack of survival difference between the treatment groups. Further studies are needed to assess whether high-dose bicalutamide monotherapy can provide equivalent efficacy to castration in patients with M1 prostate cancer.
  •  
344.
  • Ulrich, Jason D., et al. (författare)
  • ApoE facilitates the microglial response to amyloid plaque pathology
  • 2018
  • Ingår i: Journal of Experimental Medicine. - : ROCKEFELLER UNIV PRESS. - 0022-1007 .- 1540-9538. ; 215:4, s. 1047-1058
  • Tidskriftsartikel (refereegranskat)abstract
    • One of the hallmarks of Alzheimers disease is the presence of extracellular diffuse and fibrillar plaques predominantly consisting of the amyloid-beta (A beta) peptide. Apolipoprotein E (ApoE) influences the deposition of amyloid pathology through affecting the clearance and aggregation of monomeric A beta in the brain. In addition to influencing A beta metabolism, increasing evidence suggests that apoE influences microglial function in neurodegenerative diseases. Here, we characterize the impact that apoE has on amyloid pathology and the innate immune response in APPPS1 Delta E9 and APPPS1-21 transgenic mice. We report that Apoe deficiency reduced fibrillar plaque deposition, consistent with previous studies. However, fibrillar plaques in Apoe-deficient mice exhibited a striking reduction in plaque compaction. Hyperspectral fluorescent imaging using luminescent conjugated oligothiophenes identified distinct A beta morphotypes in Apoe-deficient mice. We also observed a significant reduction in fibrillar plaque-associated microgliosis and activated microglial gene expression in Apoe-deficient mice, along with significant increases in dystrophic neurites around fibrillar plaques. Our results suggest that apoE is critical in stimulating the innate immune response to amyloid pathology.
  •  
345.
  • Vandenput, Liesbeth, 1974, et al. (författare)
  • Update of the fracture risk prediction tool FRAX : a systematic review of potential cohorts and analysis plan
  • 2022
  • Ingår i: Osteoporosis International. - : Springer. - 0937-941X .- 1433-2965. ; 33:10, s. 2103-2136
  • Forskningsöversikt (refereegranskat)abstract
    • Summary: We describe the collection of cohorts together with the analysis plan for an update of the fracture risk prediction tool FRAX with respect to current and novel risk factors. The resource comprises 2,138,428 participants with a follow-up of approximately 20 million person-years and 116,117 documented incident major osteoporotic fractures.Introduction: The availability of the fracture risk assessment tool FRAX® has substantially enhanced the targeting of treatment to those at high risk of fracture with FRAX now incorporated into more than 100 clinical osteoporosis guidelines worldwide. The aim of this study is to determine whether the current algorithms can be further optimised with respect to current and novel risk factors.Methods: A computerised literature search was performed in PubMed from inception until May 17, 2019, to identify eligible cohorts for updating the FRAX coefficients. Additionally, we searched the abstracts of conference proceedings of the American Society for Bone and Mineral Research, European Calcified Tissue Society and World Congress of Osteoporosis. Prospective cohort studies with data on baseline clinical risk factors and incident fractures were eligible.Results: Of the 836 records retrieved, 53 were selected for full-text assessment after screening on title and abstract. Twelve cohorts were deemed eligible and of these, 4 novel cohorts were identified. These cohorts, together with 60 previously identified cohorts, will provide the resource for constructing an updated version of FRAX comprising 2,138,428 participants with a follow-up of approximately 20 million person-years and 116,117 documented incident major osteoporotic fractures. For each known and candidate risk factor, multivariate hazard functions for hip fracture, major osteoporotic fracture and death will be tested using extended Poisson regression. Sex- and/or ethnicity-specific differences in the weights of the risk factors will be investigated. After meta-analyses of the cohort-specific beta coefficients for each risk factor, models comprising 10-year probability of hip and major osteoporotic fracture, with or without femoral neck bone mineral density, will be computed.Conclusions: These assembled cohorts and described models will provide the framework for an updated FRAX tool enabling enhanced assessment of fracture risk (PROSPERO (CRD42021227266)).
  •  
346.
  • Veiga, Lene H. S., et al. (författare)
  • A Pooled Analysis of Thyroid Cancer Incidence Following Radiotherapy for Childhood Cancer
  • 2012
  • Ingår i: Radiation Research. - Lawrence : Radiation Research Society. - 0033-7587 .- 1938-5404. ; 178:4, s. 365-376
  • Tidskriftsartikel (refereegranskat)abstract
    • Childhood cancer five-year survival now exceeds 70-80%. Childhood exposure to radiation is a known thyroid carcinogen; however, data are limited for the evaluation of radiation dose-response at high doses, modifiers of the dose-response relationship and joint effects of radiotherapy and chemotherapy. To address these issues, we pooled two cohort and two nested case-control studies of childhood cancer survivors including 16,757 patients, with 187 developing primary thyroid cancer. Relative risks (RR) with 95% confidence intervals (CI) for thyroid cancer by treatment with alkylating agents, anthracyclines or bleomycin were 3.25 (0.9-14.9), 4.5 (1.4-17.8) and 3.2 (0.8-10.4), respectively, in patients without radiotherapy, and declined with greater radiation dose (RR trends, P = 0.02, 0.12 and 0.01, respectively). Radiation dose-related RRs increased approximately linearly for <10 Gy, leveled off at 10-15-fold for 10-30 Gy and then declined, but remained elevated for doses >50 Gy. The fitted RR at 10 Gy was 13.7 (95% CI: 8.0-24.0). Dose-related excess RRs increased with decreasing age at exposure (P < 0.01), but did not vary with attained age or time-since-exposure, remaining elevated 25+ years after exposure. Gender and number of treatments did not modify radiation effects. Thyroid cancer risks remained elevated many decades following radiotherapy, highlighting the need for continued follow up of childhood cancer survivors. (C) 2012 by Radiation Research Society
  •  
347.
  • Veiga, Lene H. S., et al. (författare)
  • Thyroid Cancer after Childhood Exposure to External Radiation : An Updated Pooled Analysis of 12 Studies
  • 2016
  • Ingår i: Radiation Research. - 0033-7587 .- 1938-5404. ; 185:5, s. 473-484
  • Tidskriftsartikel (refereegranskat)abstract
    • Studies have causally linked external thyroid radiation exposure in childhood with thyroid cancer. In 1995, investigators conducted relative risk analyses of pooled data from seven epidemiologic studies. Doses were mostly <10 Gy, although childhood cancer therapies can result in thyroid doses >50 Gy. We pooled data from 12 studies of thyroid cancer patients who were exposed to radiation in childhood (ages <20 years), more than doubling the data, including 1,070 (927 exposed) thyroid cancers and 5.3 million (3.4 million exposed) person-years. Relative risks increased supralinearly through 2-4 Gy, leveled off between 10-30 Gy and declined thereafter, remaining significantly elevated above 50 Gy. There was a significant relative risk trend for doses <0.10 Gy (P < 0.01), with no departure from linearity (P = 0.36). We observed radiogenic effects for both papillary and nonpapillary tumors. Estimates of excess relative risk per Gy (ERR/Gy) were homogeneous by sex (P = 0.35) and number of radiation treatments (P = 0.84) and increased with decreasing age at the time of exposure. The ERR/Gy estimate was significant within ten years of radiation exposure, 2.76 (95% CI, 0.94-4.98), based on 42 exposed cases, and remained elevated 50 years and more after exposure. Finally, exposure to chemotherapy was significantly associated with thyroid cancer, with results supporting a nonsynergistic (additive) association with radiation.
  •  
348.
  • Velasco, Andres, et al. (författare)
  • Investigation of vertical carbon nanosheet growth and its potential for microsupercapacitors
  • 2021
  • Ingår i: Journal of Physics: Conference Series. - : IOP Publishing. - 1742-6588 .- 1742-6596. ; 1837:1
  • Konferensbidrag (refereegranskat)abstract
    • One of the biggest applications that are coming with the Internet of Things (IoT) are miniaturized sensor networks that connect wirelessly to each other and the internet. Microsupercapacitors (MSCs) are ideal to power these devices, with large cyclability and lifetime. Porous carbons are the material of choice for these devices, but their morphology and manufacturing are far from optimized. Vertically oriented graphene MSCs have shown great promise due to their high specific surface areas and conductivity. In this work, the growth of vertically aligned carbon nanosheets (CNS) on 2-inch wafers has been studied, and it has been used as active material to manufacture MSC and transmission line model (TLM) wafers. The fabricated CNS MSC devices show a capacitance of 7.4 ?F (50.7 ?F/cm2, normalized to the area of the electrodes), a five-times increase from previous results obtained by the group.
  •  
349.
  •  
350.
  • Vyas, Agin, 1992, et al. (författare)
  • A micromachined coupled-cantilever for piezoelectric energy harvesters
  • 2018
  • Ingår i: Micromachines. - : MDPI AG. - 2072-666X. ; 9:5
  • Tidskriftsartikel (refereegranskat)abstract
    • This paper presents a demonstration of the feasibility of fabricating micro-cantilever harvesters with extended stress distribution and enhanced bandwidth by exploiting an M-shaped two-degrees-of-freedom design. The measured mechanical response of the fabricated device displays the predicted dual resonance peak behavior with the fundamental peak at the intended frequency. This design has the features of high energy conversion efficiency in a miniaturized environment where the available vibrational energy varies in frequency. It makes such a design suitable for future large volume production of integrated self powered sensors nodes for the Internet-of-Things
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 341-350 av 371
Typ av publikation
tidskriftsartikel (288)
konferensbidrag (37)
forskningsöversikt (15)
rapport (8)
annan publikation (7)
bokkapitel (6)
visa fler...
doktorsavhandling (5)
samlingsverk (redaktörskap) (1)
bok (1)
visa färre...
Typ av innehåll
refereegranskat (330)
övrigt vetenskapligt/konstnärligt (34)
populärvet., debatt m.m. (4)
Författare/redaktör
Anderson, Peter (86)
Enoksson, Peter, 195 ... (28)
Lundgren, Per, 1968 (25)
Larsson, Mattias (17)
Hansson, Bill (13)
Rämert, Birgitta (13)
visa fler...
Brenner, Hermann (12)
Norrving, Bo (12)
Anderson, Harald (12)
Weiderpass, Elisabet ... (11)
Hankey, Graeme J. (10)
Lotufo, Paulo A. (10)
Kuzmenko, Volodymyr, ... (10)
Schlyter, Fredrik (10)
Rännbäck, Linda-Mari ... (10)
Galbany, Lluís (9)
Chanock, Stephen J (9)
Bennett, Derrick A. (9)
Peters, Ulrike (9)
Shibuya, Kenji (9)
Bell, Michelle L (9)
McKee, Martin (8)
Lundqvist, Peter (8)
Esteghamati, Alireza (8)
Farzadfar, Farshad (8)
Feigin, Valery L. (8)
Jonas, Jost B. (8)
Khang, Young-Ho (8)
Lopez, Alan D. (8)
Lozano, Rafael (8)
Malekzadeh, Reza (8)
Naghavi, Mohsen (8)
Pereira, David M. (8)
Thrift, Amanda G. (8)
Vos, Theo (8)
Werdecker, Andrea (8)
Xu, Gelin (8)
Estep, Kara (8)
Moradi-Lakeh, Maziar (8)
Kim, Daniel (8)
Salomon, Joshua A. (8)
Tonelli, Marcello (8)
Anderson, Christophe ... (8)
Stein, Dan J (8)
Fereshtehnejad, Seye ... (8)
Hoy, Damian G. (8)
Abd-Allah, Foad (8)
De Leo, Diego (8)
Hsairi, Mohamed (8)
Degenhardt, Louisa (8)
visa färre...
Lärosäte
Lunds universitet (88)
Sveriges Lantbruksuniversitet (73)
Uppsala universitet (64)
Karolinska Institutet (54)
Göteborgs universitet (52)
Stockholms universitet (51)
visa fler...
Chalmers tekniska högskola (40)
Umeå universitet (32)
Linköpings universitet (20)
Kungliga Tekniska Högskolan (12)
Högskolan Dalarna (11)
Linnéuniversitetet (9)
Örebro universitet (8)
Mittuniversitetet (8)
Jönköping University (7)
Mälardalens universitet (5)
Malmö universitet (5)
RISE (5)
Högskolan Kristianstad (4)
Gymnastik- och idrottshögskolan (4)
Karlstads universitet (3)
Handelshögskolan i Stockholm (2)
Södertörns högskola (2)
Luleå tekniska universitet (1)
Högskolan i Gävle (1)
Högskolan i Borås (1)
visa färre...
Språk
Engelska (366)
Svenska (5)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (169)
Medicin och hälsovetenskap (126)
Teknik (44)
Lantbruksvetenskap (34)
Samhällsvetenskap (30)
Humaniora (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy